Vetsys Pharmaceutical
Vetsys Pharmaceutical
In the contemporary pharmaceutical landscape, the demand for CE Certified Topical Creams has transcended traditional wound care. Today, "Topical Delivery" represents a sophisticated bio-engineering field focused on localized treatment and systemic transdermal absorption. As a leading Topical Creams Manufacturer, Zhengzhou Vetsys Pharmaceutical Co., Ltd. recognizes the shift toward non-invasive delivery systems that bypass first-pass metabolism in the liver, thereby increasing bioavailability and reducing gastrointestinal side effects.
The global dermatological and veterinary cream market is projected to grow at a CAGR of 6.5% through 2030, driven by the rise in chronic skin conditions and the professionalization of livestock care.
The integration of nanotechnology and lipid-based carriers (SLNs) into ointments is revolutionizing how active pharmaceutical ingredients (APIs) penetrate the stratum corneum.
CE Certification is no longer an option but a prerequisite. Strict adherence to EU Annex 1 for sterile products and Annex 15 for qualification and validation ensures global market access.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has spent nearly two decades defining the gold standard in animal and human pharmaceutical production. With a registered capital of 30 million RMB, our infrastructure is designed to handle complex chemical syntheses and biological extractions.
Vetsys distinguishes itself through a robust independent research institute. Our team of world-class scientists works tirelessly across five specialized laboratories to bridge the gap between theoretical pharmacology and practical application. Whether it is a specialized 30g Topical Anesthetic Ointment or a high-purity herbal extract, our products carry the hallmark of clinical efficacy and safety.
Our production lines are a testament to the "Smart Factory" concept. By combining Mold Injection, Blow Molding, and automated Assembly, we control the entire lifecycle of the product—from the formulation of the cream to the ergonomic design of the applicator or tube.
Unlike standard manufacturers, Vetsys employs a Multi-Phase Quality Management System. This includes:
As a global Topical Creams Supplier, we understand that "compliance" varies by region. Our CE marking ensures entry into the European Economic Area, while our GMP certifications are recognized throughout Asia, Africa, and South America.
Technical files, risk assessments, and clinical evaluation reports (CER) are fully documented for all CE-marked medical products.
Optimized supply chain routes for temperature-sensitive ointments, ensuring product integrity from factory to pharmacy.
Multi-language packaging and localized dosage instructions to comply with various national health authorities.
Looking toward 2025-2030, Vetsys is investing heavily in Green Pharmaceutical Chemistry. This includes the development of biodegradable tubes, the reduction of organic solvents in cream bases, and the expansion into Organic & Bio-based Topical Solutions. Our mission is to balance therapeutic efficacy with environmental stewardship.
